Abstract
Safety concerns have been raised about clozapine-induced cardiotoxicity particularly in young patients. The exact mechanism of clozapine cardiotoxicity has not yet been thoroughly studied. This study aimed to investigate the possible mechanisms of clozapine-induced cardiotoxicity in a rat model. Young male Wistar rats were treated with clozapine (10, 15 and 25 mg/kg/day, i.p.) for 21 days. Haemodynamic and echocardiographic studies were performed for assessment of cardiac functions. Heart sections were studied histopathologically and immunohistochemically. Serum and cardiac markers of cardiotoxicity, oxidative stress, inflammation and apoptosis were evaluated. Heart sections of clozapine-treated animals showed increased cardiac inflammation that correlated with the clozapine dose. Serum levels of CK-MB and LDH levels increased, as did cardiac levels of TNF-α, MDA, NO, myeloperoxidase, 8-OHdG, caspase-3 and NF-κB p65. In contrast, GSH levels and GSH-Px activity decreased. Furthermore, immunohistochemical examination of the heart sections showed positive immunostaining for both 3-nitrotyrosine and caspase-3 in all clozapine-treated groups. Clozapine, particularly in relatively high doses, has a clear cardiotoxic effect. This cardiotoxicity is accompanied by increased myocardial oxidative stress, inflammatory cytokines, DNA damage and apoptosis with attenuation in antioxidant defences, thus explaining the previously reported myocarditis and pericarditis during clozapine therapy in clinical studies.
Similar content being viewed by others
References
Green, A. I., Tohen, M., Patel, J. K., Banov, M., DuRand, C., Berman, I., et al. (2000). Clozapine in the treatment of refractory psychotic mania. American Journal of Psychiatry, 157, 982–986.
Kargieman, L., Riga, M. S., Artigas, F., & Celada, P. (2012). Clozapine reverses phencyclidine-induced desynchronization of prefrontal cortex through a 5-HT(1A) receptor-dependent mechanism. Neuropsychopharmacology, 37, 723–733.
Killian, J. G., Kerr, K., Lawrence, C., & Celermajer, D. S. (1999). Myocarditis and cardiomyopathy associated with clozapine. The Lancet, 354, 1841–1845.
Markovic, J., Momcilov-Popin, T., Mitrovic, D., Ivanovic-Kovacevic, S., Sekuli, S., & Stojsic-Milosavljevic, A. (2011). Clozapine-induced pericarditis. African Journal of Psychiatry (Johannesbg), 14, 236–238.
Patel, J. J., Lisi, P. A., Lathara, Z., & Lipchik, R. J. (2012). Clozapine-induced peripheral and pleural fluid eosinophilia. Annals of Pharmacotherapy, 46(2), e4.
Wang, J. F., Min, J. Y., Hampton, T. G., Amende, I., Yan, X., Malek, S., et al. (2008). Clozapine-induced myocarditis: role of catecholamines in a murine model. European Journal of Pharmacology, 592(1–3), 123–127.
Haack, M. J., Bak, M. L., Beurskens, R., Maes, M., Stolk, L. M., & Delespaul, P. A. (2003). Toxic rise of clozapine plasma concentrations in relation to inflammation. European Neuropsychopharmacology, 13, 381–385.
Mishra, P., & Samanta, L. (2012). Oxidative stress and heart failure in altered thyroid States. Scientific World Journal, 2012, 741861.
Solaini, G., & Harris, D. A. (2005). Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochemical Journal, 390(Pt 2), 377–394.
Gioda, C. R., de Oliveira Barreto, T., Prímola-Gomes, T. N., de Lima, D. C., Campos, P. P., Capettini Ldos, S., et al. (2010). Cardiac oxidative stress is involved in heart failure induced by thiamine deprivation in rats. American Journal of Physiology Heart and Circulatory Physiology, 298, H2039–H2045.
Watanabe, K., Ohta, Y., Nakazawa, M., Higuchi, H., Hasegawa, G., Naito, M., et al. (2000). Low dose carvedilol inhibits progression of heart failure in rats with dilated cardiomyopathy. British Journal of Pharmacology, 130, 1489–1495.
Bishop, C., Chu, T. M., & Shihabi, Z. K. (1971). Single stable reagent for creatine kinase assay. Clinical Chemistry, 17, 548–550.
Whitaker, J. E. (1969). A general colorimetric produced for the estimation of enzymes, which are linked the NADHNAD System. Clinica Chimica Acta, 24, 23–27.
Beutler, B., & Cerami, A. (1987). Cachectin: More than a tumor necrosis factor. New England Journal of Medicine, 316, 379–385.
Green, L., Wanger, D., Glogowski, J., Skipper, P., Wishnok, J., & Tannenbaum, S. (1982). Analysis of nitrate, nitrite and (15 N) nitrate in biological fluid. Analytical Biochemistry, 126, 131–138.
Beutler, E., Duron, O., & Kelly, M. B. (1963). Improved method for determination of blood glutathione. Journal of Laboratory and Clinical Medicine, 61, 882–887.
Paglia, D. E., & Valentine, W. E. (1967). Studies on quantitative and qualitative characterization of erythrocyte glutathione peroxidase. Journal of Laboratory and Clinical Medicine, 70, 158–169.
Kong, L., Andrassy, M., Chang, J. S., Huang, C., Asai, T., Szabolcs, M. J., et al. (2008). PKCβ modulates ischemia–reperfusion injury in the heart. American Journal of Physiology Heart and Circulatory Physiology, 294, H1862–H1870.
Kelly, D. L., Conley, R. R., Richardson, C. M., Tamminga, C. A., & Carpenter, W. T, Jr. (2003). Adverse effects and laboratory parameters of high-dose olanzapine vs. clozapine in treatment-resistant schizophrenia. Annals of Clinical Psychiatry, 15, 181–186.
Merrill, D. B., Ahmari, S. E., Bradford, J. M., & Lieberman, J. A. (2006). Myocarditis during clozapine treatment. American Journal of Psychiatry, 163, 204–208.
Wehmeier, P. M., Heiser, P., & Remschmidt, H. (2005). Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine. Journal of Clinical Pharmacy and Therapeutics, 30, 91–96.
Kemp, M., Donovan, J., Higham, H., & Hooper, J. (2004). Biochemical markers of myocardial injury. British Journal of Anaesthesia, 93, 63–73.
Frangogiannis, N. G., Smith, C. W., & Entman, M. L. (2002). The inflammatory response in myocardial infarction. Cardiovascular Research, 53, 31–47.
Williams, D. P., O’Donnell, C. J., Maggs, J. L., Leeder, J. S., Uetrecht, J., Pirmohamed, M., & Park, B. K. (2003). Bioactivation of clozapine by murine cardiac tissue in vivo and in vitro. Chemical Research in Toxicology, 16, 1359–1364.
Pirmohamed, M., Williams, D., Madden, S., Templeton, E., & Park, B. K. (1995). Metabolism and bioactivation of clozapine by human liver in vitro. Journal of Pharmacology and Experimental Therapeutics, 272, 984–990.
Pollmächer, T., Hinze-Selch, D., & Mullington, J. (1996). Effects of clozapine on plasma cytokine and soluble cytokine receptor levels. Journal of Clinical Psychopharmacology, 16, 403–409.
Shin, W. S., Szuba, A., & Rockson, S. G. (2002). The role of chemokines in human cardiovascular pathology: Enhanced biological insights. Atherosclerosis, 160, 91–102.
Cai, X., Lu, W., Yang, Y., Yang, J., Ye, J., & Gu, Z. (2013). Digitoflavone inhibits IκBα kinase and enhances apoptosis induced by TNF-α through down regulation of expression of nuclear factor κB-regulated gene products in human pancreatic cancer cells. PLoS One, 8, 77126.
Leung, J. Y., Barr, A. M., Procyshyn, R. M., Honer, W. G., & Pang, C. C. (2012). Cardiovascular side effects of antipsychotic drugs: The role of the autonomic nervous system. Pharmacology & Therapeutics, 135, 113–122.
Breier, A., Buchanan, R. W., Waltrip, R. W., Listwak, S., Holmes, C., & Goldstein, D. S. (1994). The effect of clozapine on plasma norepinephrine: Relationship to clinical efficacy. Neuropsychopharmacology., 10, 1–7.
Pacher, P., Schulz, R., Liaudet, L., & Szabo, C. (2005). Nitrosative stress and pharmacological modulation of heart failure. Trends in Pharmacological Sciences, 26, 302–310.
Li, S., Jiao, X., Tao, L., Liu, H., Cao, Y., Lopez, B. L., et al. (2007). Tumor necrosis factor-alpha in mechanic trauma plasma mediates cardiomyocyte apoptosis. American Journal of Physiology Heart and Circulatory Physiology, 293, H1847–H1852.
Hogan, K., Ahmed, O., & Markos, F. (2007). N-desmethylclozapine an M1 receptor agonist enhances nitric oxide’s cardiac vagal facilitation in the isolated innervated rat right atrium. Autonomic Neuroscience, 137, 51–55.
Ishiyama, S., Hiroe, M., Nishikawa, T., Abe, S., Shimojo, T., & Ito, H. (1997). Nitric oxide contributes to the progression of myocardial damage in experimental autoimmune myocarditis in rats. Circulation, 95, 489–496.
Cannon, R. O. (1998). Role of nitric oxide in cardiovascular disease: Focus on the endothelium. Clinical Chemistry, 44(8 Pt 2), 1809–1819.
Heiser, P., Sommer, O., Schmidt, A. J., Clement, H. W., Hoinkes, A., Hopt, U. T., et al. (2010). Effects of antipsychotics and vitamin C on the formation of reactive oxygen species. Journal of Psychopharmacology, 24, 1499–1504.
Nussler, A., DiSilvio, M., Billiar, T., Hoffman, R., Geller, D., Selby, R., et al. (1992). Stimulation of the nitric oxide pathway in human hepatocytes by cytokines and endotoxin. Journal of Experimental Medicine, 176, 261–264.
Finkel, M. S., Oddis, C. V., Jacob, T. D., Watkins, S. C., Hattler, B. G., & Simmons, R. L. (1992). Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science, 257, 387–389.
Acknowledgments
This work was financially supported by Najran University Program for Health and Medical Research Grants, Grant No. (NU 3/10). This study was carried out in the College of Medicine, Najran University, Najran, Saudi Arabia. The authors acknowledge Dr. M.A. Abdul-Rahman Pathology Department, Faculty of Medicine, Najran University for his help in immunohistochemical examination.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Abdel-Wahab, B.A., Metwally, M.E. Clozapine-Induced Cardiotoxicity: Role of Oxidative Stress, Tumour Necrosis Factor Alpha and NF-κβ. Cardiovasc Toxicol 15, 355–365 (2015). https://doi.org/10.1007/s12012-014-9304-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12012-014-9304-9